JESUS GONZALEZ: Open Payments
NPI 1336336288 · GOLDTHWAITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 25 payments from 9 companies in 2025. Trend: 2023 $1,679 · 2024 $1,897 · 2025 $528
Food & beverage: $443Education: $85
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 6 | $199 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| Novo Nordisk Inc | 5 | $90 |
| Ardelyx, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $36 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: ULTOMIRIS, Ozempic, SOLIRIS, AIRSUPRA, IBSRELA, OTEZLA, ZENPEP, XIFAXAN.
Industry payments across TX — which companies pay providers there.
